| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 08/13/2002 | US6433171 Dipeptide derivatives |
| 08/13/2002 | US6432993 Substituted fused heterocyclic compound |
| 08/13/2002 | US6432981 Cyclopentyl modulators of chemokine receptor activity |
| 08/13/2002 | US6432974 Circadian rhythym, sleep, sexual, nervous system and psychological disorders; antidepressants, anxiolytic agents; drug abuse, drug dependence, and schizophrenia treatment |
| 08/13/2002 | US6432949 Amide derivatives useful as inhibitors of the production of cytokines |
| 08/13/2002 | US6432945 Dipeptide derivatives |
| 08/13/2002 | US6432941 Vanadium compounds for treating cancer |
| 08/13/2002 | CA2095526C Compound and compositions useful as antifungal agents |
| 08/08/2002 | WO2002060907A1 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient |
| 08/08/2002 | WO2002060901A1 Pest controllers |
| 08/08/2002 | WO2002060900A2 Antagonists of mcp-1 function and methods of use thereof |
| 08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | WO2002060879A2 Bacterial gyrase inhibitors and uses thereof |
| 08/08/2002 | WO2002060445A1 Kappa opioid receptor ligands |
| 08/08/2002 | WO2002060442A1 Novel forms of 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo (1,2-a)pyridine-6-carboxamide |
| 08/08/2002 | WO2002060441A1 Novel forms of 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo (1,2-a)pyridine-6-carboxamide |
| 08/08/2002 | WO2002060440A1 Novel forms of 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo (1,2-a)pyridine-6-carboxamide |
| 08/08/2002 | WO2002060438A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | WO2002060382A2 Novel compounds and uses thereof |
| 08/08/2002 | WO2002040505A3 Dibenzoxazepine alpha v integrin receptor antagonist |
| 08/08/2002 | WO2002034716A3 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 08/08/2002 | WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | WO2002024650A3 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 08/08/2002 | WO2002018327A3 Guanidinobenzamides as mc4-r agonists |
| 08/08/2002 | WO2002014269A3 2,4-substituted pyridine derivatives |
| 08/08/2002 | WO2002010140A3 Imidazolyl derivatives |
| 08/08/2002 | WO2002008211A3 Benzothiazepines and their use as antihyperlipidemics |
| 08/08/2002 | WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 08/08/2002 | WO2001098268A3 Piperidine amides as modulators of chemokine receptor activity |
| 08/08/2002 | WO2001093840A3 Ligands of integrin receptors |
| 08/08/2002 | US20020107397 Provide polymeric resin products having low polydispersity. |
| 08/08/2002 | US20020107392 Quinolinone derivatives |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | US20020107262 Substituted imidazopyridines |
| 08/08/2002 | US20020107261 Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors |
| 08/08/2002 | US20020107258 Inhibition of human telomerase by a G-quadruplex-interaction compound |
| 08/08/2002 | US20020107257 Treatments for restless legs syndrome |
| 08/08/2002 | US20020107251 4-(hetero)aryl-3-oxo-3,4-dihydropyrido(2,3-b)pyrazine derivatives; prophylactic or therapeutic treatment of phosphodiesterase IV and tumor necrosis factor mediated diseases |
| 08/08/2002 | US20020107247 Method of treating sexual disturbances |
| 08/08/2002 | US20020107235 Carbamate and hydroxy groups containing phenanthrene derivatives; useful to treat obesity, diabetes and inflammation |
| 08/08/2002 | CA2436774A1 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | CA2436130A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | CA2432997A1 Antagonists of mcp-1 function and methods of use thereof |
| 08/07/2002 | EP1228376A1 Fluorescent compounds for use in industrial water systems |
| 08/07/2002 | EP1228147A1 Dye labeled imidazoquinoline compounds |
| 08/07/2002 | EP1228071A1 Pharmaceutically active isoindoline derivatives |
| 08/07/2002 | EP1228069A2 Bicyclic and tricyclic heteroaromatic compounds |
| 08/07/2002 | EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity |
| 08/07/2002 | EP1228066A2 Sulfonamide derivatives |
| 08/07/2002 | EP1228060A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 08/07/2002 | EP1228059A1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |
| 08/07/2002 | EP1228045A2 Heterocyclic cytotoxic agents |
| 08/07/2002 | EP1228044A2 Pyrrolo imidazole derivatives and their use as medicaments |
| 08/07/2002 | EP1228043A1 Isoquinoline and quinazoline deivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity |
| 08/07/2002 | EP1012151B1 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating cns and stress-related disorders |
| 08/07/2002 | CN1362960A Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones |
| 08/07/2002 | CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/07/2002 | CN1362953A Pyrazole compositions useful as inhibitors of ERK |
| 08/07/2002 | CN1362952A 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 08/07/2002 | CN1362884A Preventives/remedies for liver diseases |
| 08/07/2002 | CN1088709C Amine compound and its acid addition salt |
| 08/07/2002 | CN1088702C Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 08/06/2002 | US6429315 Process for preparing N6-substituted adenosine derivatives |
| 08/06/2002 | US6429313 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 08/06/2002 | US6429211 Administering praziquantel to mammals to treat neurological and abortigenical diseases caused by coccidia (such as equine protozoal myeloencephalitis); reduced side effects |
| 08/06/2002 | CA2236707C Fused tropane-derivatives, their preparation and use |
| 08/01/2002 | WO2002059267A2 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | WO2002059134A1 Transition metal complexes with proton sponges as ligands |
| 08/01/2002 | WO2002059129A2 Substituted tetracyclic pyridoindoles as serotonin agonists and antagonists |
| 08/01/2002 | WO2002059124A2 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 08/01/2002 | WO2002059123A2 Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds |
| 08/01/2002 | WO2002059122A1 ANTI-CANCER 2,3-DIHYDRO-1H-PYRROLO[3,2-f]QUINOLINE COMPLEXES OF COBALT AND CHROMIUM |
| 08/01/2002 | WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059093A1 Methods and compositions for binding nucleic acid molecules |
| 08/01/2002 | WO2002059083A2 Novel compounds |
| 08/01/2002 | WO2002059082A2 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| 08/01/2002 | WO2002058844A1 Stable free nitroxyl radicals as oxidation catalysts and process for oxidation |
| 08/01/2002 | WO2002058704A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 08/01/2002 | WO2002058695A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 08/01/2002 | WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 08/01/2002 | US20020103383 Selective 5-HT6 receptor ligands |
| 08/01/2002 | US20020103382 Serotonin (5-HT) subtype 6 receptor (5-HT6); 3-(2-aminoethyl)indole derivatives; drug screening |
| 08/01/2002 | US20020103373 Tricyclic benzodiazepines as vasopressin receptor antagonists |
| 08/01/2002 | US20020103372 Drying crystals of a mirtazapine hydrate to give anhydrous mirtazapine crystals having moisture <= 0.6% by weight when crystals are stored in the air having relative humidity 75% at 25 degree C. under atmospheric pressure for 500 hours |
| 08/01/2002 | US20020103243 Sulfamoyl compounds and agricultural and horticultural fungicides |
| 08/01/2002 | US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same |
| 08/01/2002 | US20020103230 Heterocyclic compounds |
| 08/01/2002 | US20020103209 Serotonergic modulators; for treatment of disorders of the central nervous system including psychotic disorders, hypertension and vascular disorders, migraine |
| 08/01/2002 | US20020103208 Useful in treatment of anxiety disorders, affective disorders such as depression, psychosis and schizophrenia, Parkinson's disease |
| 08/01/2002 | US20020103203 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis |
| 08/01/2002 | US20020103188 Peroxisome Proliferator-Activated Receptors (PPAR); diabetes and obesity; 3-(4-(2-(10,1-Dihydro-dibenzo(b,f)azepin-5-yl)ethoxy)-pheny)-2-ethoxy -propionic acid, for example |
| 08/01/2002 | US20020103161 Novel heterocycles |
| 08/01/2002 | US20020102435 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye |
| 08/01/2002 | DE10103244A1 Übergangsmetallkomplexe mit Protonenschwämmen als Liganden Transition metal complexes with proton sponges as ligands |
| 08/01/2002 | CA2435773A1 Transition metal complexes with proton sponges as ligands |
| 08/01/2002 | CA2435653A1 Anti-cancer 2,3-dihydro-1h-pyrrolo[3,2-f]quinoline complexes of cobalt and chromium |
| 08/01/2002 | CA2435047A1 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | CA2434558A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 08/01/2002 | CA2432122A1 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |